Zhou BG[Author] - Search Results

Year	Number of Results
1987	2
1989	1
1999	1
2001	2
2002	1
2005	1
2006	4
2009	1
2010	1
2012	2
2013	1
2014	1
2015	1
2016	5
2017	2
2018	5
2019	3
2020	3
2021	2

1

Saccharomyces boulardii as an adjuvant therapy for Helicobacter pylori eradication: A systematic review and meta-analysis with trial sequential analysis.

Zhou BG, Chen LX, Li B, Wan LY, Ai YW. Zhou BG, et al. Helicobacter. 2019 Oct;24(5):e12651. doi: 10.1111/hel.12651. Epub 2019 Aug 14. Helicobacter. 2019. PMID: 31414551

2

Molecular mechanisms of hepatic insulin resistance in nonalcoholic fatty liver disease and potential treatment strategies.

Zhang CH, Zhou BG, Sheng JQ, Chen Y, Cao YQ, Chen C. Zhang CH, et al. Among authors: zhou bg. Pharmacol Res. 2020 Sep;159:104984. doi: 10.1016/j.phrs.2020.104984. Epub 2020 Jun 2. Pharmacol Res. 2020. PMID: 32502637 Review.

3

Association study of the functional variants of the GLIS3 gene with risk of knee osteoarthritis.

Zhang JL, Zhang CL, Zhou BG, Lei BY, Zhang B, Yang HT. Zhang JL, et al. Among authors: zhou bg. Clin Rheumatol. 2021 Mar;40(3):1039-1046. doi: 10.1007/s10067-019-04871-0. Epub 2020 Jul 17. Clin Rheumatol. 2021. PMID: 32681364

4

Regulatory effect of Zuojin Pill on correlation with gut microbiota and Treg cells in DSS-induced colitis.

Zhou BG, Liu FC, Zhao HM, Zhang XY, Wang HY, Liu DY. Zhou BG, et al. J Ethnopharmacol. 2020 Nov 15;262:113211. doi: 10.1016/j.jep.2020.113211. Epub 2020 Jul 30. J Ethnopharmacol. 2020. PMID: 32739566

5

Association between Helicobacter pylori infection and nonalcoholic fatty liver disease: A systematic review and meta-analysis of observational studies.

Zhou BG, Yang HJ, Xu W, Wang K, Guo P, Ai YW. Zhou BG, et al. Helicobacter. 2019 Jun;24(3):e12576. doi: 10.1111/hel.12576. Epub 2019 Mar 25. Helicobacter. 2019. PMID: 30907050

6

Three-dimensional shear wave elastography for differentiation of breast lesions: An initial study with quantitative analysis using three orthogonal planes.

Wang Q, Li XL, He YP, Alizad A, Chen S, Zhao CK, Guo LH, Bo XW, Ren WW, Zhou BG, Xu HX. Wang Q, et al. Among authors: zhou bg. Clin Hemorheol Microcirc. 2019;71(3):311-324. doi: 10.3233/CH-180388. Clin Hemorheol Microcirc. 2019. PMID: 29865044

7

Effect of Puerarin Regulated mTOR Signaling Pathway in Experimental Liver Injury.

Zhou BG, Zhao HM, Lu XY, Zhou W, Liu FC, Liu XK, Liu DY. Zhou BG, et al. Front Pharmacol. 2018 Oct 23;9:1165. doi: 10.3389/fphar.2018.01165. eCollection 2018. Front Pharmacol. 2018. PMID: 30405406 Free PMC article.

8

Erzhi Pill^® Protected Experimental Liver Injury Against Apoptosis via the PI3K/Akt/Raptor/Rictor Pathway.

Zhao HM, Zhang XY, Lu XY, Yu SR, Wang X, Zou Y, Zuo ZY, Liu DY, Zhou BG. Zhao HM, et al. Among authors: zhou bg. Front Pharmacol. 2018 Mar 27;9:283. doi: 10.3389/fphar.2018.00283. eCollection 2018. Front Pharmacol. 2018. PMID: 29636693 Free PMC article.

9

Two-dimensional shear wave elastography for differential diagnosis between mastitis and breast malignancy.

Liu SQ, Liu YP, Zhou BG, Deng XH, Li XL, Xiang LH, Ren WW, Xu HX. Liu SQ, et al. Among authors: zhou bg. Clin Hemorheol Microcirc. 2018;70(3):347-354. doi: 10.3233/CH-180400. Clin Hemorheol Microcirc. 2018. PMID: 29710692

10

Matrine reversed multidrug resistance of breast cancer MCF-7/ADR cells through PI3K/AKT signaling pathway.

Zhou BG, Wei CS, Zhang S, Zhang Z, Gao HM. Zhou BG, et al. J Cell Biochem. 2018 May;119(5):3885-3891. doi: 10.1002/jcb.26502. Epub 2018 Jan 22. J Cell Biochem. 2018. PMID: 29130495

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results